Zante Greg

EDGAR CIK 0001264949

Viking Therapeutics, Inc. - VKTX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($2.61) M
-78,878 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
07/29/2026
07/29/2026
Sell
-21,217 @ $33.47
 ($710,141) 212,204 (-9.09%) Direct
01/05/2026
01/05/2026
Sell
-57,661 @ $32.90
 ($1,896,969) 189,891 (-23.29%) Direct